<p>联合健康集团（NYSE:UNH - 获取免费报告）在摩根士丹利发布的一份研究报告中将其目标股价从 342.00 美元下调至 325.00 美元，Benzinga 报道。该券商目前对这家医疗保健综合体的股票给予 “增持” 评级。摩根士丹利的目标股价意味着与该股票之前收盘价相比，潜在上涨幅度为 8.85%。</p>
<ul>
<li>巴菲特的神秘买入揭晓，这是一项对 UNH 的重大押注</li>
</ul>
<p>其他股票研究分析师最近也对该股票发布了报告。雷蒙德·詹姆斯金融公司在 5 月 14 日的研究报告中将联合健康集团的股票评级从 “强力买入” 下调至 “市场表现”。富国银行在 8 月 4 日的研究报告中将联合健康集团的目标股价从 306.00 美元下调至 267.00 美元，并对该公司给予 “增持” 评级。KeyCorp 在 7 月 30 日的研究报告中将联合健康集团的目标股价从 400.00 美元下调至 350.00 美元，并对该公司给予 “增持” 评级。TD Cowen 在 5 月 19 日的研究报告中将联合健康集团的股票评级从 “买入” 下调至 “持有”，并设定了 308.00 美元的目标股价。最后，TD 证券在 5 月 19 日的研究报告中重申了 “持有” 评级，并对联合健康集团的股票设定了 308.00 美元的目标股价（之前为 520.00 美元）。十五位投资分析师对该股票给予了买入评级，六位给予了持有评级，三位给予了卖出评级。根据 MarketBeat 的数据，联合健康集团目前的平均评级为 “适度买入”，平均目标股价为 365.38 美元。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<p><strong>获取我们对联合健康集团的最新分析</strong></p>
<h2>联合健康集团价格表现</h2>
<ul>
<li>HCA 医疗保健能否复兴市场最弱的行业？</li>
</ul>
<p>NYSE:UNH 在周三下跌 5.6520 美元，达到 298.5880 美元。该股票的交易量为 7,282,663 股，而其平均交易量为 12,787,148 股。该公司的市值为 2704.2 亿美元，市盈率为 12.95，市盈增长比率为 1.99，贝塔值为 0.43。联合健康集团的 1 年最低价为 234.60 美元，1 年最高价为 630.73 美元。该公司的速动比率为 0.85，流动比率为 0.85，债务股本比率为 0.73。该股票的 50 日移动平均价格为 289.03 美元，200 日移动平均价格为 393.55 美元。</p>
<p>联合健康集团（NYSE:UNH - 获取免费报告）最后一次公布财报是在 7 月 29 日，医疗保健综合体报告该季度每股收益为 4.08 美元，低于分析师一致预期的 4.45 美元（差额为 0.37 美元）。联合健康集团的股本回报率为 23.32%，净利润率为 5.04%。该公司在该季度的收入为 1116.2 亿美元，而一致预期为 1117.5 亿美元。在去年同期，该公司每股收益为 6.80 美元。该公司的收入同比增长 12.9%。联合健康集团已将其 2025 财年的指导目标设定为每股收益 16.000。研究分析师预测联合健康集团今年将发布 29.54 的每股收益。</p>
<h2>内部买卖</h2>
<ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
<p>在其他联合健康集团的新闻中，首席执行官帕特里克·休·康威在 6 月 10 日的交易中出售了 589 股该股票。这些股票的平均售价为 305.00 美元，总价值为 179,645.00 美元。出售完成后，首席执行官在公司中持有 10,398 股，价值为 3,171,390 美元。这笔交易代表了他们持有的股票减少了 5.36%。该出售在与 SEC 的法律文件中披露，文件可通过此链接获取。当前 0.28% 的股票由公司内部人士持有。</p>
<h2>联合健康集团的机构交易</h2>
<p>一些对冲基金最近调整了对该股票的持有。金融管理专业公司在第一季度将其在联合健康集团的持股增加了 0.8%。金融管理专业公司现在拥有 2,224 股该医疗保健综合体的股票，价值为 1,165,000 美元，此前在上一季度又购买了 17 股。全球财富策略与顾问在第一季度将其在联合健康集团的持股增加了 28.6%。全球财富策略与顾问现在拥有 90 股该医疗保健综合体的股票，价值为 47,000 美元，此前在上一季度又购买了 20 股。Kolinsky Wealth Management LLC 在第四季度将其在联合健康集团的持股增加了 1.0%。Kolinsky Wealth Management LLC 现在拥有 2,135 股该医疗保健综合体的股票，价值为 1,080,000 美元，此前在上一季度又购买了 21 股。退休规划集团在第一季度将其在联合健康集团的持股增加了 5.1%。退休规划集团现在拥有 430 股该医疗保健综合体的股票，价值为 225,000 美元，此前在上一季度又购买了 21 股。最后，净值顾问集团在第一季度将其在联合健康集团的持股增加了 0.6%。净值顾问集团现在拥有 3,642 股该医疗保健综合体的股票，价值为 1,907,000 美元。机构投资者和对冲基金持有该公司 87.86% 的股票。</p>
<h2>联合健康集团公司简介</h2>
<p>（获取免费报告）</p>
<p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合医疗、Optum Health、Optum Insight 和 Optum Rx。联合医疗部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险覆盖的人群的州项目提供的医疗保健福利产品和服务。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过联合健康集团</li>
<li>如何一步步购买便宜股票</li>
<li>核能第二季度收益的赢家和输家</li>
<li>内部交易可能不会告诉你你想的那样</li>
<li>现在有两个强大的力量支持英特尔的转型</li>
<li>投资者如何从盘后交易中受益</li>
<li>Archer 的飞行里程碑和防御胜利让华尔街兴奋</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
<p>在考虑联合健康集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而联合健康集团并不在名单上。</p>
<p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

<p>摩根士丹利已将联合健康（NYSE:UNH）的目标股价从 342.00 美元下调至 325.00 美元，同时维持 “增持” 评级。这个新目标暗示该股票相较于前一交易日收盘价有 8.85% 的上涨空间。其他分析师也调整了他们的评级，其中一些对该股票进行了下调。目前，联合健康的平均评级为 “适度买入”，平均目标价为 365.38 美元。该股票最近的交易价格为 298.59 美元，市值为 2704.2 亿美元，市盈率为 12.95</p>

<p>UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target cut by stock analysts at Morgan Stanley from $342.00 to $325.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an &#34;overweight&#34; rating on the healthcare conglomerate's stock. Morgan Stanley's target price would indicate a potential upside of 8.85% from the stock's previous close.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）在摩根士丹利发布的一份研究报告中将其目标股价从 342.00 美元下调至 325.00 美元，Benzinga 报道。该券商目前对这家医疗保健综合体的股票给予 “增持” 评级。摩根士丹利的目标股价意味着与该股票之前收盘价相比，潜在上涨幅度为 8.85%。</p>
</div><ul>
<li>Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH</li>
</ul>
<div class="lb-trans"><ul>
<li>巴菲特的神秘买入揭晓，这是一项对 UNH 的重大押注</li>
</ul>
</div><p>Other equities research analysts also recently issued reports about the stock. Raymond James Financial downgraded shares of UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;market perform&#34; rating in a research note on Wednesday, May 14th. Wells Fargo &amp; Company dropped their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an &#34;overweight&#34; rating for the company in a research note on Monday, August 4th. KeyCorp lowered their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, July 30th. TD Cowen downgraded shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Finally, TD Securities reaffirmed a &#34;hold&#34; rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $365.38.</p>
<div class="lb-trans"><p>其他股票研究分析师最近也对该股票发布了报告。雷蒙德·詹姆斯金融公司在 5 月 14 日的研究报告中将联合健康集团的股票评级从 “强力买入” 下调至 “市场表现”。富国银行在 8 月 4 日的研究报告中将联合健康集团的目标股价从 306.00 美元下调至 267.00 美元，并对该公司给予 “增持” 评级。KeyCorp 在 7 月 30 日的研究报告中将联合健康集团的目标股价从 400.00 美元下调至 350.00 美元，并对该公司给予 “增持” 评级。TD Cowen 在 5 月 19 日的研究报告中将联合健康集团的股票评级从 “买入” 下调至 “持有”，并设定了 308.00 美元的目标股价。最后，TD 证券在 5 月 19 日的研究报告中重申了 “持有” 评级，并对联合健康集团的股票设定了 308.00 美元的目标股价（之前为 520.00 美元）。十五位投资分析师对该股票给予了买入评级，六位给予了持有评级，三位给予了卖出评级。根据 MarketBeat 的数据，联合健康集团目前的平均评级为 “适度买入”，平均目标股价为 365.38 美元。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Analysis on UnitedHealth Group</strong></p>
<div class="lb-trans"><p><strong>获取我们对联合健康集团的最新分析</strong></p>
</div><h2>UnitedHealth Group Price Performance</h2>
<div class="lb-trans"><h2>联合健康集团价格表现</h2>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA 医疗保健能否复兴市场最弱的行业？</li>
</ul>
</div><p>NYSE:UNH traded down $5.6520 on Wednesday, reaching $298.5880. The stock had a trading volume of 7,282,663 shares, compared to its average volume of 12,787,148. The company has a market capitalization of $270.42 billion, a P/E ratio of 12.95, a price-to-earnings-growth ratio of 1.99 and a beta of 0.43. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $289.03 and a 200-day moving average price of $393.55.</p>
<div class="lb-trans"><p>NYSE:UNH 在周三下跌 5.6520 美元，达到 298.5880 美元。该股票的交易量为 7,282,663 股，而其平均交易量为 12,787,148 股。该公司的市值为 2704.2 亿美元，市盈率为 12.95，市盈增长比率为 1.99，贝塔值为 0.43。联合健康集团的 1 年最低价为 234.60 美元，1 年最高价为 630.73 美元。该公司的速动比率为 0.85，流动比率为 0.85，债务股本比率为 0.73。该股票的 50 日移动平均价格为 289.03 美元，200 日移动平均价格为 393.55 美元。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the firm posted $6.80 earnings per share. The company's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）最后一次公布财报是在 7 月 29 日，医疗保健综合体报告该季度每股收益为 4.08 美元，低于分析师一致预期的 4.45 美元（差额为 0.37 美元）。联合健康集团的股本回报率为 23.32%，净利润率为 5.04%。该公司在该季度的收入为 1116.2 亿美元，而一致预期为 1117.5 亿美元。在去年同期，该公司每股收益为 6.80 美元。该公司的收入同比增长 12.9%。联合健康集团已将其 2025 财年的指导目标设定为每股收益 16.000。研究分析师预测联合健康集团今年将发布 29.54 的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
</div><p>In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.28% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他联合健康集团的新闻中，首席执行官帕特里克·休·康威在 6 月 10 日的交易中出售了 589 股该股票。这些股票的平均售价为 305.00 美元，总价值为 179,645.00 美元。出售完成后，首席执行官在公司中持有 10,398 股，价值为 3,171,390 美元。这笔交易代表了他们持有的股票减少了 5.36%。该出售在与 SEC 的法律文件中披露，文件可通过此链接获取。当前 0.28% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Trading of UnitedHealth Group</h2>
<div class="lb-trans"><h2>联合健康集团的机构交易</h2>
</div><p>A number of hedge funds have recently modified their holdings of the stock. Financial Management Professionals Inc. lifted its holdings in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Global Wealth Strategies &amp; Associates lifted its holdings in shares of UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies &amp; Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after buying an additional 21 shares in the last quarter. Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group lifted its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近调整了对该股票的持有。金融管理专业公司在第一季度将其在联合健康集团的持股增加了 0.8%。金融管理专业公司现在拥有 2,224 股该医疗保健综合体的股票，价值为 1,165,000 美元，此前在上一季度又购买了 17 股。全球财富策略与顾问在第一季度将其在联合健康集团的持股增加了 28.6%。全球财富策略与顾问现在拥有 90 股该医疗保健综合体的股票，价值为 47,000 美元，此前在上一季度又购买了 20 股。Kolinsky Wealth Management LLC 在第四季度将其在联合健康集团的持股增加了 1.0%。Kolinsky Wealth Management LLC 现在拥有 2,135 股该医疗保健综合体的股票，价值为 1,080,000 美元，此前在上一季度又购买了 21 股。退休规划集团在第一季度将其在联合健康集团的持股增加了 5.1%。退休规划集团现在拥有 430 股该医疗保健综合体的股票，价值为 225,000 美元，此前在上一季度又购买了 21 股。最后，净值顾问集团在第一季度将其在联合健康集团的持股增加了 0.6%。净值顾问集团现在拥有 3,642 股该医疗保健综合体的股票，价值为 1,907,000 美元。机构投资者和对冲基金持有该公司 87.86% 的股票。</p>
</div><h2>UnitedHealth Group Company Profile</h2>
<div class="lb-trans"><h2>联合健康集团公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合医疗、Optum Health、Optum Insight 和 Optum Rx。联合医疗部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险覆盖的人群的州项目提供的医疗保健福利产品和服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>How to Buy Cheap Stocks Step by Step</li>
<li>Who Won and Who Lost in Nuclear Energy’s Q2 Earnings</li>
<li>Insider Trades May Not Tell You What You Think</li>
<li>2 Powerful Forces Now Back Intel's Turnaround</li>
<li>How Can Investors Benefit From After-Hours Trading</li>
<li>Archer's Flight Milestones &amp; Defense Wins Excite Wall Street</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过联合健康集团</li>
<li>如何一步步购买便宜股票</li>
<li>核能第二季度收益的赢家和输家</li>
<li>内部交易可能不会告诉你你想的那样</li>
<li>现在有两个强大的力量支持英特尔的转型</li>
<li>投资者如何从盘后交易中受益</li>
<li>Archer 的飞行里程碑和防御胜利让华尔街兴奋</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而联合健康集团并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

摩根士丹利的分析师将联合健康集团（NYSE:UNH）的目标股价下调至 325.00 美元